USPTO serial 79382663
H CUSABIO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 7, 2025
- Examiner
- ALBANO, ASHLEY C
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with H CUSABIO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Nazly Aileen Bayramoglu
Nazly Aileen Bayramoglu Bayramoglu Law Offices LLC1540 West Warm Springs Road Suite 100No. 9 Chegongzhuang Avenue,Henderson, NV 89014Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Protein in raw material form for scientific and medical research; chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; chemical preparations for scientific purposes, other than for medical or veterinary use; test paper, chemical; chemical reagents, other than for medical or veterinary purposes; preparations of microorganisms, other than for medical and veterinary use; bacterial preparations, other than for medical and veterinary use; diagnostic preparations, other than for medical or veterinary purposes; plant growth regulating preparations | ACTIVE | — |
| 005 | Antibiotics for human use; Vaccines for human use; Medicinal preparations for the treatment of infectious diseases and for use in oncology; chemical reagents for medical or veterinary purposes; diagnostic preparations for medical purposes; enzyme preparations for medical purposes; pharmaceutical preparations, namely, antibody drugs for the treatment of cancer, tumors, anti-rejection of organ transplantation; pharmaceutical preparations for the treatment of tumors, cancer and infectious diseases, namely, antibodies, antibody derivatives, antibody-drug conjugates for medical purposes; chemical preparations for the diagnosis of pregnancy; medicinal drinks; chemical preparations for pharmaceutical purposes, namely, chemical reagents; injectable medicinal solutions, namely, injectable pharmaceuticals for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; dietetic substances adapted for medical use, namely, dietetic preparations, protein dietary supplements; antiseptics | ACTIVE | — |
| 010 | Apparatus for artificial respiration; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; breath gas analyzers for medical diagnostics; medical diagnostic instruments for the analysis of body fluids; medical instruments for analysing and identifying bacteria; Medical apparatus and instruments, namely, flow cytometers and flow-based analyzers providing cell and particle analysis, detection, or counting for medical, clinical, medical diagnostic, and therapeutic uses; Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing for medical purposes; dental apparatus, electric; galvanic therapeutic appliances; beds specially made for medical purposes; feeding bottles; orthopedic articles, namely, orthopedic braces; suture materials | ACTIVE | — |
| 042 | Research and development of new products for others; technological research in the field of biotechnology, antigens, proteins, antibodies, microorganisms, cells, bioscience and immunology; conducting technical project studies, namely, conducting scientific project feasibility studies; conducting technical project studies in the field of biotechnology, antigens, proteins, antibodies, microorganisms, cells, bioscience and immunology; conducting technical project studies in the field of custom design and development of chemical reagents and biochemical assays; scientific laboratory services; cosmetic research; chemical analysis; chemistry services, namely, consultation in the field of chemistry, research and development services in the field of immunocytochemistry, chemical and biomolecular analysis, research in the fields of chemistry and biochemistry, chemical research laboratory services, consultancy in the field of biochemistry, research and development services in the field of biochemistry; chemical research; biological research; bacteriological research | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by WUHAN HUAMEI BIOTECH CO., LTD.
- Other trademarks owned by WUHAN HUAMEI BIOTECH CO., LTD.
- Other trademarks owned by WUHAN HUAMEI BIOTECH CO., LTD.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named H CUSABIO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 26, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 4, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 4, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 26, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 8, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 8, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Apr 7, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 7, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 7, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 19, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 19, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 13, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 9, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 4, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 4, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 4, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 10, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 8, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 20, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 20, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 29, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 28, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 13, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 17, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 13, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 9, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |